Skip to main content
OpenTrials
Completed

NCT Number: NCT05240677

Endoscopy in CKD With Iron Deficiency Anemia

Iron deficiency anemia is very common in CKD patients. Data about gastrointestinal lesions in Arab patients are insufficient.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Iron deficiency anemia without gastrointestinal symptoms needs to be assessed in patients with chronic kidney disease.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • Patients with eGFR is less than 60 ml/m/1.73 m2.
  • Patients with iron deficiency anemia.
  • Absence of gastrointestinal symptoms.

Treatment and study plan

Upper GIT endoscopy

Procedure

Upper gastrointestinal endoscpy for all participants and gastric biopsy for histopathological examination for suspicious lesions

Primary outcomes

  1. Rate of upper gastrointestinal endoscopic findings In chronic kidney disease patients with iron deficiency anemia

    Time frame: 6 months

    Detect rate of upper GIT lesions in asymptomatic CKD patients with iron deficiency anemia using endoscopy followed by biopsy and histopathological examination

Sponsors and collaborators

Lead sponsor

Walid Ahmed Ragab Abdelhamid

Other Gov

Registry information

Official study title

Value of Esophageogastroduodenscopy in Assessment of Chronic Kidney Disease Patients With Iron Deficiency Anemia Without Gastrointestinal Symptoms

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Feb 15, 2022
Registry last updated
Jan 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.